Systemic lupus erythematosus: Clinical presentations

Autoimmunity Reviews

Volumn 10, Issue 1, 2010, Pages 43-45

  Smith, Paul P ^a   Gordon, Caroline ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

Author keywords

Clinical features; Clinical manifestations; Clinical presentations; Epidemiology; Serology; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DOUBLE STRANDED DNA ANTIBODY;

ABNORMAL LABORATORY RESULT; AGE DISTRIBUTION; CLINICAL FEATURE; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE EXACERBATION; GASTROINTESTINAL DISEASE; HEART DISEASE; HUMAN; INFLAMMATION; KIDNEY DISEASE; LUNG DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; MENTAL DISEASE; MUSCULOSKELETAL DISEASE; PATIENT MONITORING; PROGNOSIS; RELAPSE; REMISSION; REVIEW; RISK ASSESSMENT; SKIN MANIFESTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

AGE FACTORS; AUTOANTIBODIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; SEX FACTORS;

EID: 78149361405     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2010.08.016     Document Type: Review

References (11)

1. Johnson A.E., Gordon C., Palmer R.G., Bacon P.A. The prevalence and incidence of systemic lupus erythematosus in Birmingham, UK, related to ethnicity and country of birth. Arthritis Rheum 1995, 38:551-558.
2. Petri M. Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2002, 16(5):847-858.
3. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277.
4. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997 Sep, 40(9):1725.
5. Gordon C. Long-term complications of systemic lupus erythematosus. Rheumatology (Oxford). 2002, 41:1095-1100.
6. Sultan A.M., Ioannou Y., Isenberg D.A. A review of gastrointestinal manifestations of systemic lupus srythematosus. Rheumatology 1999, 38:917-932.
7. Gordon P., Khamasthta M., Rosenthal E., et al. Anti-52kDa Ro, anti-60kDa Ro ad anti-La antibody profiles in neonatal lupus. J Rheumatol 2004, 31:2480-2487.
8. Moroni G., Radice A., Giammarresi G., Quaglini S., Gallelli B., Leoni A., Vecchi M.L., Messa P., Sinico R. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Ann Rheum Dis 2009, 68:234-237.
9. Griffiths B., Mosca M., Gordon C. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol 2005, 19(5):685-708.
10. Fessel W.J. Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch Intern Med 1974 Dec, 134(6):1027-1035.
11. Bernatsky S., Boivin J.F., Joseph L., et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006 Aug, 54(8):2550-2557.